Authors
Latest:
Managing logistics partnerships in uncertain timesOutsourced services can provide significant financial and risk-avoidance benefits
Latest:
Laying the foundation for a national system for evidence generationSharing clinical data—EvGen—will improve both drug development and health outcomes analysis
Latest:
Big Data in pharma cold chain logisticsCollecting and reporting data in near real time cuts costs and reduces risk
Latest:
New approaches to specialty distributionA direct-distribution model could save expense for payers and patients while providing better service
Latest:
Navigating the patient journey after rare disease diagnosisCommercial teams can prepare for overcoming predictable hurdles
Latest:
Entering the Brazilian Pharmaceutical MarketStable economics and growing healthcare concerns make Brazil one of the top emerging markets, with a current growth rate >20%
Latest:
Retail Pharmacies and the Health and Wellness RenaissanceFollowing are excerpts from the keynote presentation of Steven C. Anderson, president and CEO of the National Assn. of Chain Drug Stores, at its annual meeting, Palm Beach, FL, Apr. 25.
Latest:
Get Ready for EHRs as the Essential Communications Platform for PharmaElectronic health-record systems (EHRs) are bringing needed drug information to the point of care for prescribers
Latest:
Innovative models to address cell- and gene-therapy (CGT) payer challengesCarving out CGTs for payment systems involving government intervention may be an answer
Latest:
Understanding the companion-diagnostics environmentWhile the pharma industry is growing more dependent on companion diagnostics, test developers face an uncertain business model
Latest:
How cloud-based IT systems address FDA validation requirementsPaper validation records will disappear in the face of continuous validation
Latest:
How to Think About Companion DiagnosticsBoth promise and peril exist for drugmakers in working with diagnostic tests to commercialize new medications or refine the applicability of existing ones
Latest:
A new approach to pharma supply-chain collaborationTeam-Up seeks to bring manufacturers and logistics providers together
Latest:
Bringing New Science, and New Partners, Into the Drug Development ProcessToday’s evolving healthcare environment calls for more collaboration in bringing drugs to market
Latest:
Ten integrated imperatives for pharma commercial transformationThe pharma industry needs to go farther in adapting to new marketplace realities
Latest:
Adopting the TAPA cargo security standards in the pharmaceutical industrySecuring your supply chain
Latest:
Economic Considerations For REMSDrug sponsors have options in both how the new FDA risk programs are structured and how to execute them
Latest:
Improving health outcomes through customized adherence messagesOptimized multichannel communications will prevent illness and save lives
Latest:
Is There Life After the Lab?Today’s uncertain work environment obliges you to manage your career and financial status to keep your options open
Latest:
Future look: The Impact of Biosimilars on OncologyMarketing strategies will adjust with the advent of biosimilars
Latest:
Forecasting Returns When Patents ExpireOverestimating product reserves as loss of exclusivity (LoE) approaches can be a $75-million mistake
Latest:
CAR-T Therapies: Three Supply Chain ConsiderationsAs more of these novel—and costly—cell therapies gain approval, revamped strategies around scaling, coordination and workflow are critical to their launch
Latest:
HPCLC Spring Meeting recapLogistics managers in life sciences and personal care focus on transportation capacity
Latest:
Lessons learned on bona fide service fees and fair market value-is there a 'right answer'?Recent regulatory actions and court cases highlight the importance of due diligence in reporting the value of service fees when federal reimbursements are concerned. The financial consequences can be substantial
Latest:
True Software-as-a-Service (SaaS) Transforms Sales Automation Systems to Make Upgrades PainlessMulti-tenant sales-force automation (SFA) systems are coping with an increasingly complex regulatory environment
Latest:
In an EHR era, adverse event reporting takes on a new lookAs the number of adverse events (AEs) grows year by year, regulators and industry managers are looking at automated systems to handle the burden
Latest:
Cancer care in the US -- looking back, looking forwardBegin thinking of your business as a 'disease' company vs. a 'drug' company
